Primary cutaneous diffuse large B-cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression

被引：0
|
作者：
Okada, Yosuke [1 ]
Sone, Takehiro [1 ]
Takada, Kohei [1 ]
Ogata, Hiraku [1 ]
Saito, Keita [1 ]
Kimura, Fumihiko [1 ]
机构：
[1] Natl Def Med Coll Hosp, Div Haematol, Dept Internal Med, Saitama, Japan
来源：
EJHAEM | 2022年 / 3卷 / 01期
关键词：
D O I：
10.1002/jha2.364
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [41] BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma
    Monni, O
    Joensuu, H
    Franssila, K
    Klefstrom, J
    Alitalo, K
    Knuutila, S
    BLOOD, 1997, 90 (03) : 1168 - 1174
  • [42] BCL2 mutations in diffuse large B-cell lymphoma
    Schuetz, J. M.
    Johnson, N. A.
    Morin, R. D.
    Scott, D. W.
    Tan, K.
    Ben-Nierah, S.
    Boyle, M.
    Slack, G. W.
    Marra, M. A.
    Connors, J. M.
    Brooks-Wilson, A. R.
    Gascoyne, R. D.
    LEUKEMIA, 2012, 26 (06) : 1383 - 1390
  • [43] BCL2 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Schuetz, J.
    Johnson, N.
    Morin, R.
    Marra, M.
    Connors, J.
    Brooks-Wilson, A.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2011, 22 : 207 - 207
  • [44] Clinical Impact of MYC, BCL2, BCL6, and MALT1 Alterations in Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era
    Valera, S.
    Cardesa, T.
    Climent, F.
    Romagosa, V.
    Gonzalez, E.
    Arenillas, L.
    Serrano, S.
    Mate, J. L.
    Salamero, O.
    Lopez-Guillermo, A.
    Campo, E.
    Colomo, L.
    LABORATORY INVESTIGATION, 2010, 90 : 326A - 326A
  • [45] Clinical Impact of MYC, BCL2, BCL6, and MALT1 Alterations in Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era
    Valera, S.
    Cardesa, T.
    Climent, F.
    Ramagosa, V.
    Gonzalez, E.
    Arenillas, L.
    Serrano, S.
    Mate, J. L.
    Salamero, O.
    Lopez-Guillermo, A.
    Campo, E.
    Colomo, L.
    MODERN PATHOLOGY, 2010, 23 : 326A - 326A
  • [46] BCL2 mutations in diffuse large B-cell lymphoma
    J M Schuetz
    N A Johnson
    R D Morin
    D W Scott
    K Tan
    S Ben-Nierah
    M Boyle
    G W Slack
    M A Marra
    J M Connors
    A R Brooks-Wilson
    R D Gascoyne
    Leukemia, 2012, 26 : 1383 - 1390
  • [47] Primary cutaneous diffuse large B-cell lymphoma, leg type: Two Bcl-2 negative cases
    Chiang, Nicole Yi Zhen
    Uddin, Aleem
    Abdullah, Anthony
    Thompson, Donna
    Abdullah, Parveen
    Velangi, Shireen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB148 - AB148
  • [48] Prognostic importance of BCL6 rearrangements in diffuse large B-cell lymphoma with respect to Bcl6 protein levels and primary lymphoma site
    Tzankov, Alexandar
    Schneider, Aurelia
    Hoeller, Sylvia
    Dirnhofer, Stephan
    HUMAN PATHOLOGY, 2009, 40 (07) : 1055 - 1056
  • [49] Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"
    McPhail, Ellen D.
    Maurer, Matthew J.
    Ketterling, Rhett P.
    Macon, William R.
    Feldman, Andrew L.
    Kurtin, Paul J.
    Witzig, Thomas E.
    Vaidya, Rakhee
    Habermann, Thomas M.
    BLOOD, 2016, 128 (22)
  • [50] Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Lue, Jennifer K.
    Luttwak, Efrat
    Rivas-Delgado, Alfredo
    Irawan, Helen
    Boardman, Alexander
    Caron, Philip C.
    David, Kevin
    Epstein-Peterson, Zachary
    Falchi, Lorenzo
    Ghione, Paola
    Hamlin, Paul
    Horwitz, Steven M.
    Intlekofer, Andrew M.
    Johnson, William
    Kumar, Anita
    Moskowitz, Alison
    Noy, Ariela
    Palomba, M. Lia
    Steiner, Ralphael
    Stuver, Robert
    Torka, Pallawi
    Vardhana, Santosha
    Zelenetz, Andrew D.
    Schoder, Heiko
    Imber, Brandon
    Yahalom, Joachim
    Zhang, Yanming
    Galera, Pallavi
    Dogan, Ahmet
    Aypar, Umut
    Salles, Gilles
    BLOOD CANCER JOURNAL, 2024, 14 (01):
12345